Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab

(2015) M. Putt et al.   CLINICAL CHEMISTRY

Cardiotoxicity of anticancer treatments

(2015) Michael S. Ewer et al.   Nature Reviews Cardiology

Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis

(2015) Seongseok Yun et al.   POSTGRADUATE MEDICAL JOURNAL

Anthracycline-Dependent Cardiotoxicity and Extracellular Matrix Remodeling

(2014) Dragana Nikitovic et al.   CHEST

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2014) J. C. Plana et al.   European Heart Journal-Cardiovascular Imaging

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

(2014) Virginia Shalkey Hahn et al.   Journal of the American Heart Association

Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy

(2013) Sinziana Seicean et al.   Circulation-Heart Failure

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

(2013) Xavier Bosch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease

(2013) Torbjørn Omland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease

(2013) Brandon C. Drafts et al.   JACC-Cardiovascular Imaging

Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial

(2012) Siri Lagethon Heck et al.   CARDIOLOGY

Cancer drugs and the heart: importance and management

(2012) T. M. Suter et al.   EUROPEAN HEART JOURNAL

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

(2012) Mehmet G. Kaya et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

(2011) F. S. Apple et al.   CLINICAL CHEMISTRY

Anthracycline-Induced Cardiomyopathy

(2010) Daniela Cardinale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

(2009) Renske Altena et al.   LANCET ONCOLOGY